Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]

Detalles Bibliográficos
Autores principales: Lienggonegoro, Lisa Andriani, Dany, Frans, Panjaitan, Novaria Sari Dewi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479559/
https://www.ncbi.nlm.nih.gov/pubmed/37675186
http://dx.doi.org/10.2147/NDT.S435561
_version_ 1785101616888676352
author Lienggonegoro, Lisa Andriani
Dany, Frans
Panjaitan, Novaria Sari Dewi
author_facet Lienggonegoro, Lisa Andriani
Dany, Frans
Panjaitan, Novaria Sari Dewi
author_sort Lienggonegoro, Lisa Andriani
collection PubMed
description
format Online
Article
Text
id pubmed-10479559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104795592023-09-06 Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter] Lienggonegoro, Lisa Andriani Dany, Frans Panjaitan, Novaria Sari Dewi Neuropsychiatr Dis Treat Letter Dove 2023-09-01 /pmc/articles/PMC10479559/ /pubmed/37675186 http://dx.doi.org/10.2147/NDT.S435561 Text en © 2023 Lienggonegoro et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Letter
Lienggonegoro, Lisa Andriani
Dany, Frans
Panjaitan, Novaria Sari Dewi
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
title Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
title_full Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
title_fullStr Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
title_full_unstemmed Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
title_short Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
title_sort serum levels of tumor necrosis factor-α and vascular endothelial growth factor in the subtypes of clinical high risk individuals: a prospective cohort study [letter]
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479559/
https://www.ncbi.nlm.nih.gov/pubmed/37675186
http://dx.doi.org/10.2147/NDT.S435561
work_keys_str_mv AT lienggonegorolisaandriani serumlevelsoftumornecrosisfactoraandvascularendothelialgrowthfactorinthesubtypesofclinicalhighriskindividualsaprospectivecohortstudyletter
AT danyfrans serumlevelsoftumornecrosisfactoraandvascularendothelialgrowthfactorinthesubtypesofclinicalhighriskindividualsaprospectivecohortstudyletter
AT panjaitannovariasaridewi serumlevelsoftumornecrosisfactoraandvascularendothelialgrowthfactorinthesubtypesofclinicalhighriskindividualsaprospectivecohortstudyletter

Ejemplares similares